Health Care & Life Sciences » Pharmaceuticals | Oxford BioMedica PLC

Oxford BioMedica PLC | Cash Flow

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
12,763.00
10,798.00
14,083.00
11,313.00
5,668.00
13,915
Depreciation, Depletion & Amortization
1,067.00
1,099.00
1,627.00
3,675.00
4,375.00
4,357
Other Funds
2,363.00
1,988.00
2,516.00
1,156.00
6,631.00
7,725
Funds from Operations
9,333.00
7,711.00
9,940.00
6,482.00
7,924.00
10,547
Changes in Working Capital
1,622.00
1,732.00
3,140.00
766.00
141.00
2,292
Net Operating Cash Flow
10,955.00
5,979.00
13,080.00
5,716.00
7,783.00
8,255
Capital Expenditures
937.00
5,577.00
16,716.00
6,458.00
1,969.00
Purchase/Sale of Investments
5,105.00
-
-
-
-
Net Investing Cash Flow
4,168.00
5,577.00
16,716.00
6,458.00
1,969.00
Issuance/Reduction of Debt, Net
-
1,000.00
24,812.00
-
8,361.00
Net Financing Cash Flow
-
23,582.00
24,956.00
17,497.00
8,746.00
Net Change in Cash
6,787.00
12,026.00
4,840.00
5,323.00
1,006.00
Free Cash Flow
11,794.00
11,556.00
29,796.00
12,174.00
9,752.00
Change in Capital Stock
-
22,582.00
144.00
17,497.00
385.00

About Oxford BioMedica

View Profile
Address
Windrush Court
Oxford Oxfordshire OX4 6LT
United Kingdom
Employees -
Website http://oxfordbiomedica.co.uk
Updated 07/08/2019
Oxford Biomedica Plc is a biopharmaceutical company, which engages in the research and development of gene and cell therapy. The firm also provides bioprocessing and process development services to third parties. It operates through the Platform and Product segment.